ASCO GU 2020 comparing quality of life results in patients randomized in the STAMPEDE trial, pivotal study in cementing novel drug combinations in the standard of care of localized and advanced prostate cancer
Pedro Barata and Nizar Tannir delve into the eight-year results of the CheckMate-214 trial, showcasing the sustained efficacy of ipilimumab and nivolumab (ipi/nivo) in advanced…
Sam Chang engages with Roger Li to delve into the TAR-210 study, focusing on bladder-based intravesical therapy targeting FGFR3 in non-muscle invasive bladder cancer (NMIBC)…
Zach Klaassen and Kelvin Moses discuss the continuum of care for metastatic hormone-sensitive prostate cancer, focusing on triplet therapy. Dr. Moses highlights the ideal patient…
Jeffrey Tosoian presents a new tool in prostate cancer diagnosis with the development and validation of an 18-gene urine test designed to identify clinically significant…
Alicia Morgans hosts Shankar Siva who sheds light on the innovative use of Stereotactic Ablative Body Radiotherapy (SBRT/SABR) for treating oligometastatic kidney cancer. Dr. Siva…
Prostate cancer, PROpel trial, homologous recombination repair mutation (HRRm), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Olaparib, Abiraterone, Olaparib plus Abiraterone Versus Placebo plus Abiraterone for Metastatic…
prostate cancer, advanced prostate cancer, androgen deprivation therapy (ADT), Relugolix, Dosing of Relugolix, gonadotropin-releasing hormone (GnRH) receptor antagonist, HERO study, abiraterone acetate, apalutamide, metastatic castration-sensitive…
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Unlocking Precision Care: Germline & Somatic Literacy in Prostate Cancer –…
Shreeya Popat, Jennifer Chyu, and Una Lee discuss the overlooked impact of mesh sling complications on the partners of urologic patients. Their research, focusing on…
Ashish Kamat and Matthew Galsky discuss a phase 2 trial on organ sparing for muscle-invasive bladder cancer, published in Nature Medicine. Dr. Galsky highlights the…
